Organ procurement organizations and transplant programs are entering the most consequential regulatory stretch in the history of the U.S. transplant system. We help you get ahead of it.
Introducing Our UNOS & OPO Compliance Practice

Team Lead – UNOS & OPO Compliance Consulting
Corporate Investigation Consulting is expanding its healthcare compliance bench with the addition of Dana Smith, DNP, APRN, ANP-BC, CVNP-BC, VAD-C, AACC, who brings more than 30 years of nursing experience — including over 23 years as a nurse practitioner and more than a decade dedicated to solid organ transplantation — to our UNOS & OPO compliance practice. Dr. Smith’s clinical background spans heart, kidney, liver, and lung transplantation, with a primary focus on heart transplant and advanced heart failure, including hands-on management of patients requiring mechanical circulatory support.
Beyond clinical practice, Dr. Smith served in program leadership as Director of Thoracic Transplant and Ventricular Assist Device Programs at a major multi-organ transplant institute, leading a multidisciplinary team of cardiothoracic surgeons, transplant physicians, program coordinators, advanced practice providers, and pharmacists, and using data from UNOS, SRTR, and the Intermacs Registry to drive program-level quality and performance improvement — including over 50% growth in lung transplant volume in a single year.
Dr. Smith’s distinguishing strength is guiding transplant programs through high-stakes regulatory review and out the other side stronger. Early in her tenure as director, she led her team through an intensive period of scrutiny from The Joint Commission and UNOS — managing rigorous investigations and frequent, detailed regulatory reporting — and worked collaboratively across leadership to move the program to a fully compliant, better-resourced state, including building a new Quality Team that raised transplant metric compliance from below 80% to a sustained 93–100%. She later shifted her focus to professional development, designing and leading education for nursing and physician teams centered on regulatory documentation, patient safety, and outcomes, and since November 2024 has served as a Solid Organ Transplant Clinical Nurse Specialist.
That combination — deep clinical practice, program leadership through regulatory crisis, and hands-on staff education — gives Dr. Smith firsthand insight into UNOS requirements, survey readiness, and the operational and cultural changes it takes to sustain long-term compliance. She works alongside our existing team of former federal agents and healthcare compliance consultants, who bring decades of experience on the government side of healthcare audit, investigation, and enforcement — pairing someone who has lived through regulatory scrutiny from inside a transplant program with a firm that knows how federal surveyors and investigators build their case.
What Is UNOS & OPO Compliance?
The U.S. organ donation and transplantation system runs on a layered set of rules, and the two most important names in the room are often confused. UNOS — the United Network for Organ Sharing — is the nonprofit contractor that operates the Organ Procurement and Transplantation Network (OPTN) under federal contract, setting the policies that govern how organs are matched, allocated, and tracked. CMS — the Centers for Medicare & Medicaid Services — is the federal regulator that certifies and surveys the roughly 55 Organ Procurement Organizations (OPOs) operating across the country under the Conditions for Coverage set out in 42 CFR Part 486, Subpart G.
“UNOS compliance” and “OPO compliance” therefore describe two overlapping but distinct obligations: staying aligned with OPTN policy on organ allocation, data submission, and organ tracking, and staying certified under CMS’s Conditions for Coverage, which govern everything from board governance to donor family consent documentation. In practice, an OPO or transplant program that falls out of step with one is usually at risk on the other, because both regulatory tracks pull from the same underlying operational data: referral timeliness, donor management outcomes, consent documentation, and organ disposition records.
Our UNOS & OPO compliance practice exists to help organizations manage both tracks as one integrated compliance program, rather than two separate paperwork exercises handled by different departments.
Why OPOs and Transplant Centers Need Specialized Compliance Support Right Now
The regulatory environment for organ procurement organizations changed materially heading into 2026. CMS’s proposed revisions to the OPO Conditions for Coverage (42 CFR Part 486, Subpart G) closed out a public comment period on March 31, 2026, onsite recertification surveys resumed in summer 2026 for the first time since the current outcome-measures framework took effect, and a Final Rule is anticipated before year end. Organizations classified in Tier 2 or Tier 3 under that framework should expect recertification and decertification proceedings to begin as early as January 2027 — a timeline that leaves a narrow window to build a defensible record before CMS starts making determinations.
At the same time, CMS guidance released in 2026 has sharply raised the bar on how donor family conversations are documented, how OPO staff and hospital clinical staff separate their roles, and how organizations prove — not just assert — that consent was obtained without pressure. Surveyors are now instructed to issue citations for identified deficiencies even when an organization has already corrected the underlying problem. That is a fundamentally different compliance posture than most OPOs were built for: it means your documentation has to hold up on its own, without the benefit of a post-hoc explanation from staff who remember what actually happened.
Layered on top of the clinical and family-engagement requirements are the long-standing operational obligations every OPO must satisfy: governance by an advisory board with specific clinical and community representation, data submission to OPTN and the Scientific Registry of Transplant Recipients within 30 days of month-end, seven-year record retention, monthly death record reviews at qualifying hospitals, biennial emergency preparedness planning, and written agreements with the overwhelming majority of Medicare- and Medicaid-participating hospitals in the service area.
For an OPO’s leadership and board, this creates a compliance workload that spans clinical operations, IT and data governance, hospital relations, and legal — often without the internal headcount to own all of it at once. The organizations that come through a recertification cycle cleanly are, almost without exception, the ones that treated compliance as a continuous program rather than a pre-survey scramble.
The 2026–2027 Regulatory Timeline at a Glance
For OPO and transplant leadership tracking where this cycle stands:
- March 31, 2026 — Public comment period closed on CMS’s proposed revisions to the OPO Conditions for Coverage
- Spring 2026 — CMS released updated OPO performance reports based on 2024 outcome-measure data
- Summer 2026 — Onsite recertification surveys resumed under the current outcome-measures framework
- Late 2026 — CMS Final Rule on the revised Conditions for Coverage anticipated
- January 2027 — Recertification and decertification proceedings expected to begin for organizations classified in Tier 2 and Tier 3
Who We Work With
We support the organizations that sit inside, and immediately alongside, the OPO regulatory system:
- Organ Procurement Organizations of every size, from single-state OPOs to large multi-state service areas
- Transplant centers and programs managing their own consent, documentation, and OPTN reporting obligations
- Histocompatibility and immunogenetics labs supporting the organ matching process
- Hospital systems building or expanding donation programs, DCD protocols, and designated requestor training
- Boards and executive leadership teams preparing for a recertification survey, a leadership transition, or a merger between service areas
Our Approach
We combine two vantage points that rarely sit inside the same engagement: former federal investigators who understand how CMS, HHS-OIG, and DOJ build and prove a compliance case, and hands-on OPO/UNOS expertise that understands how procurement, family services, hospital development, and QAPI functions actually operate day to day.
That combination lets us do more than write policy documents. We stress-test your program the way a surveyor or investigator would, identify the gap between what your policies say and what your records can prove, and build a defensible, documented compliance program — not a shelf binder.
Every recommendation we make is tied back to a specific regulatory requirement, a specific piece of CMS or OPTN guidance, or a specific pattern we’ve seen surveyors flag. We don’t hand you generic compliance templates; we build documentation your staff will actually use under real operating conditions, because that’s the only kind that survives contact with a surveyor.
That isn’t abstract for us. Dr. Smith has personally led a transplant program’s Quality Team through an intensive period of Joint Commission and UNOS scrutiny, taking transplant metric compliance from below 80% to a sustained 93–100% — we know what that turnaround actually requires operationally and culturally, not just what the regulation says it should look like on paper.
Our UNOS & OPO Compliance Services
We support OPOs, transplant centers, and histocompatibility labs across five core areas:
OPO Conditions for Coverage Compliance & Recertification
We assess your standing under 42 CFR Part 486 Subpart G — governance, personnel, and the outcome measures that drive your Tier classification — and build a plan to defend or improve it ahead of your next recertification survey.
- Tier status assessment and improvement planning
- Advisory board composition and governance documentation review
- Personnel credentialing and qualification audits
- Mock recertification surveys
OPTN & SRTR Data Reporting Compliance
Your Tier classification is calculated directly from the data you submit. We audit your submission timeliness, error-correction process, and seven-year retention system so the numbers CMS sees are numbers you can defend.
- 30-day submission timeliness audits
- Documented error-correction protocols
- Retention system design (electronic or paper)
- Independent data integrity spot-checks
QAPI Program & Death Record Review Compliance
We build or strengthen the data-driven Quality Assessment and Performance Improvement program CMS requires, including the monthly death record reviews mandated at qualifying trauma centers and large hospitals.
- QAPI program design and metrics selection
- Monthly death record review systems
- Adverse event policy development
- Corrective action tracking to completion
Donor Family Consent & Hospital Agreement Compliance
We rebuild your documentation standards to meet the current CMS bar for coercion-free, adequately timed family conversations, and audit your hospital agreements and designated requestor training against the 95% coverage requirement.
- Family consent documentation templates
- OPO/hospital role-separation protocol audits
- Hospital agreement drafting and renewal
- Designated requestor training compliance
CMS Survey Readiness & Decertification Defense
Whether you’re preparing for a routine recertification survey or responding to an active citation or decertification notice, we help you build the record and, if necessary, the appeal.
- Full mock survey assessments
- Corrective action plan (CAP) development
- Reconsideration and hearing representation
- Rapid-response support for urgent notices
Our Process
Every engagement follows the same disciplined methodology we use across our healthcare compliance practice:
1. Comprehensive Needs Assessment
We start by reviewing your current Tier status, prior survey findings, hospital agreements, and QAPI documentation. This isn’t a generic checklist — it’s a targeted review that identifies your highest-risk exposure points first, so early engagement effort goes where it matters most.
2. Existing Program Audit
We test what your records can actually prove against what a surveyor or OPTN auditor will ask to see. This includes pulling a sample of donor family documentation, data submission logs, and death record reviews to see whether the paper trail matches the policy on paper.
3. Strategy & Documentation
We build or rewrite the policies, protocols, and documentation templates your staff will actually use, aligned to current CMS and OPTN requirements — including the family-engagement documentation standard CMS has emphasized most heavily in 2026 guidance.
4. Implementation & Staff Training
We train procurement coordinators, hospital development staff, and designated requestors on the updated expectations, with a specific emphasis on what to document, when, and in what level of detail — the details surveyors are now trained to look for.
5. Ongoing Monitoring
We help stand up or strengthen your QAPI program so compliance is monitored continuously, not rediscovered during survey season. That means real metrics reviewed on a real cadence by your board and leadership team.
6. Survey & Audit Defense Preparedness
We prepare your organization and your board for recertification surveys and OPTN audits, and — if a citation or decertification notice is already on the table — we move directly into corrective action planning and, where needed, appeal representation.
Key Terms to Know
A quick reference for the terms that come up most often in OPO and transplant compliance work:
OPTN: the Organ Procurement and Transplantation Network, the national system connecting all organ procurement and transplant activity, operated under federal contract by UNOS.
SRTR: the Scientific Registry of Transplant Recipients, which receives outcome data used to evaluate OPO and transplant program performance.
Conditions for Coverage: the CMS regulations (42 CFR Part 486, Subpart G) an OPO must meet to remain certified for Medicare reimbursement.
Tier classification: the CMS system (Tier 1, 2, or 3) that ranks OPOs by donation-rate performance and determines recertification, competition, or decertification outcomes.
QAPI: Quality Assessment and Performance Improvement — the ongoing, data-driven self-monitoring program every OPO must operate.
CAP: a Corrective Action Plan submitted in response to a cited deficiency, documenting the fix and the evidence that it worked.
DCD: Donation after Circulatory Death, an organ donation pathway with its own protocol and documentation requirements distinct from donation after brain death.
FAQs
Do you work with OPOs directly, or only with transplant hospitals?
Both. Our practice supports OPOs, transplant centers, and histocompatibility labs, and we frequently work across the OPO-hospital relationship where compliance obligations overlap, such as hospital agreements and designated requestor training.
What is a Tier classification, and why does it matter?
Under the OPO outcome measures framework, organizations are classified into Tier 1, 2, or 3 based on donation rate performance. Tier 1 organizations receive automatic four-year recertification. Tier 2 organizations have their service area opened to competition. Tier 3 organizations receive a decertification notice. We help you understand your current standing and build a plan to improve or defend it.
What’s the difference between UNOS compliance and CMS/OPO compliance?
UNOS operates the OPTN under federal contract and sets policy on organ allocation, matching, and data submission. CMS separately certifies and surveys OPOs against the Conditions for Coverage in 42 CFR Part 486. The two overlap heavily in practice — data you submit to OPTN often becomes part of the record CMS reviews — which is why we treat them as one compliance program rather than two.
We already have internal compliance staff. Why bring in outside consultants?
Internal compliance staff are essential, but an outside review brings the perspective of former federal investigators and dedicated OPO regulatory expertise, without the blind spots that come from reviewing your own work. We also provide surge capacity ahead of a survey or in response to a citation.
How quickly can you respond if we’ve already received a CMS citation or notice?
We treat active citations and decertification notices as time-sensitive matters and can typically begin an engagement within days, including reconsideration filings, which carry a 15-business-day deadline.
Is this practice separate from your other healthcare compliance work?
No — it sits alongside our existing healthcare fraud, hospital, home health/hospice, and pharmacy compliance practices, so organizations that touch multiple parts of the healthcare regulatory system can work with one team.
Do you help with the 2026 CMS Conditions for Coverage proposed rule specifically?
Yes. We track the rulemaking process, including the closed 2026 comment period and the anticipated Final Rule, and help clients build compliance programs that anticipate the direction CMS guidance is already moving, not just the current baseline requirements.
Can you support a merger or consolidation between OPO service areas?
Yes. Service area consolidations raise their own governance, data-migration, and hospital-agreement questions, and we help organizations work through the compliance implications alongside their legal counsel.